INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2017

Gut microbiome dysbiosis and resulting uremic toxins are implicated in chronic kidney disease progression, inflammation, and increased cardiovascular risk.

This review discusses the gut microbiome in chronic kidney disease (CKD), where dysbiosis arises from qualitative and quantitative changes in microbial profiles and disruption of gut barrier function. These alterations and host responses are implicated in CKD progression, uremic toxicity, inflammation, and increased cardiovascular risk. It also addresses the gut microbiome in renal transplant patients and explores therapeutic interventions aimed at restoring intestinal dysbiosis.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Patients with chronic kidney disease and renal transplant recipients
What was measured
Gut dysbiosis, uremic toxins, CKD progression, cardiovascular risk, and inflammation

THE PAPER

Gut microbiome in chronic kidney disease: challenges and opportunities.

Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D. Transl Res, 2017.

PubMed 27187743 ↗DOI 10.1016/j.trsl.2016.04.007 ↗

Heart & arteriesGut & microbiomeKidney health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.